Cambridge-based health-tech startup PocDoc has secured £5 million in a pre-A funding round. The investment came from MMC Ventures (which recently backed Tangible and Atlas Metrics), Molten VC (which recently invested in Concretene and One Data), and Simplyhealth Ventures. Another major investor joining in this round is KHP Ventures, the first NHS-anchored venture fund, which invests in health tech innovators and supports the adoption of transformative solutions at scale across digital health and MedTech.
This is the largest pre-A raise for a UK digital diagnostics business. With this round, the total funding raised by PocDoc accounts for over £10 million. This new investment will support the company’s continued rapid growth, fuelled by its growing list of pharmacy, retail, and corporate partnerships, as well as its deepening relationships with the NHS across the UK.
Faster and smarter diagnostics
As per Glob Heart. 2024, World Health Organisation, 27 million lives are lost each year to preventable diseases. Cardio, Metabolic, and Renal (CMR) diseases are the leading cause of deaths globally and are crippling our healthcare systems. Millions of people are living with CMR diseases/at risk of CMR but have never been tested. As with many conditions accessing testing and treatment can be difficult, yet up to 90% of cases of CMR diseases could be prevented through early intervention.
Identifying those at the highest risk of disease and ensuring they receive appropriate treatment could save millions of lives and save the global economy trillions of pounds per year.
PocDoc is the future of care and it offers a smarter, faster way to make diagnostics available for all, especially those at highest risk.
PocDoc’s patented MFA (Microfluidic Assay) Platform is the first, truly portable, quantitative, digital diagnostic test platform that can perform complex multi-marker interactions to a clinically valid standard.
PocDoc’s 10-step AI diagnostic pipeline (HUESnap) is capable of accurate colorimetric quantification of multiple biomarkers in the field from a single assay, producing clinically valid concentration predictions in seconds.
Heart checks in under 10 minutes
Founded by Steve Roest, Kiran Roest, and Vladimir Gubala in 2017 in Cambridge, PocDoc is a digital health platform developed with the vision of allowing anyone with a smartphone or tablet to test themselves for a range of major diseases or conditions via a fingerprick of blood, receive a full health assessment that puts those results in context and then be offered solutions to address any health-related issues that arise.
This platform combines rapid diagnostic testing with access to healthcare pathways via the PocDoc app. PocDoc’s Healthy Heart Check is said to be the first in a series of easy-to-use home test kits that will provide a revolution in healthcare and prevent millions of premature deaths. In under 10 minutes, it provides fully quantified lipid results, heart age, and 10-year risk of cardiovascular disease, as well as access to follow-on treatment.
PocDoc’s tests are available for free in regions where the company is already working with the NHS, in community pharmacies across the UK, via online retailers such as Pharmacy2U, and on PocDoc’s website.
How is PocDoc a game-charger?
The company is revolutionising diagnostics with its innovative approach to rapid, digital health testing. By integrating at-home testing kits with an AI-powered app, it enables users to quickly assess their health and receive actionable insights. This eliminates the need for time-intensive lab visits, democratising access to essential diagnostics.
PocDoc’s focus on cardiovascular and chronic disease detection aligns with pressing global health challenges. Its scalable technology can significantly reduce healthcare burdens, particularly in underserved regions. With growing recognition and partnerships, PocDoc is poised to transform how diagnostics are delivered, empowering individuals and healthcare providers with real-time, accurate health insights.
Steve Roest, CEO and Co-founder at PocDoc, said: “Today’s announcement of our heavily oversubscribed investment round is a major endorsement of our incredible technology and our journey to date. We are delighted to see such healthy interest in our vision of revolutionising access to screening from the investment community and we’re thrilled to have Molten Ventures, MMC Ventures, and Simplyhealth Ventures investing. The inclusion of KHP Ventures as a fund backed by NHS institutions is a clear signal of our NHS traction and alignment with overall NHS priorities – we couldn’t be happier that they’re investing in our journey.”
Tim Irish, Partner at KHP Ventures, commented: “At KHP Ventures, our focus is on investing in innovators and technologies that are going to deliver the transformation required to deliver the best possible outcomes for patients, staff, and health systems, starting with the NHS. PocDoc is demonstrating excellent traction and we’re looking forward to working with Steve, Vlad, Kiran, and the team on the next phase of their growth journey.”
The post PocDoc injects £5M for health checks in under 10 minutes: Largest UK Pre-A raise in digital health appeared first on Tech Funding News.